ClinicalTrials.gov record
Study to Compare the Efficacy and Safety of Combination Treatment With Dutasteride and Tamsulosin With Tamsulosin Monotherapy, in Men With Moderate to Severe Benign Prostatic Hyperplasia
COMPLETED · NCT02058368
Trial record
NCT IDNCT02058368
Status
COMPLETED
Study type
INTERVENTIONAL
Phase
PHASE3
Enrollment
607
Conditions
Prostatic Hyperplasia
Interventions
Dutasteride 0.5mg capsules, Dutasteride placebo capsules, Tamsulosin 0.2mg tablets, Disintegrating placebo tamsulosin tablet
Locations
GSK Investigational Site, Xiame, Fujian, China, GSK Investigational Site, Guangzhou, Guangdong, China, GSK Investigational Site, Wuhan, Hubei, China, GSK Investigational Site, Suzhou, Jiangsu, China, GSK Investigational Site, Shenyang, Liaoning, China, GSK Investigational Site, Hangzhou, Zhejiang, China, GSK Investigational Site, Beijing, China, GSK Investigational Site, Beijing, China
Indexed topics
Last update
2019-01-08